Joint seminar by JETRO, NEDO, and Stanford SV-NJ
Technology Innovation Partnership (TIP) series and Stanford SV-NJ Public Forum Series
Last year, the world’s most advanced legal framework for regenerative medicine came into force in Japan, allowing provisional approval to regenerative medicine products before phase Ⅲ of clinical trials.
Along with deregulation in cell processing outsourcing, the policy was designed to make Japan the most business-friendly for regenerative medicine. This panel introduces the regulatory developments and industry perspectives, along with insights into some of the latest research in regenerative medicine at Stanford. Each speaker will speak approximately 15 minutes, followed by a 30 minute panel discussion.
Chief Executive Director, Japan External Trade Organization (JETRO) San Francisco
Program Advisor, New Energy and Industrial Development Organization (NEDO)
Professor of Genetics, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University
Director, Bio-Industry Division, Manufacturing Industries Bureau
Ministry of Economy, Trade, and Industry (METI)
Regenerative Medicine Industrialization Task Force (RMIT)
Forum for Innovative Regenerative Medicine (FIRM)
Chief Operating Officer
Fogarty Institute for Innovation
Date: June 19th (Fri) 2015
Time: 4:15 - 5:50PM, followed by networking until 6:30PM
Location: Philippines Conference Room, Encina Hall, 3rd Floor, 616 Serra St, Stanford CA 94305
Parking: Most Stanford parking spaces become available to the general public at 4pm. If street parking is not available, the basement of the Knight Management Center, accessed from campus drive, has a large underground parking lot.